Quest Diagnostics Inc

NYSE: DGX
$139.50
+$5.24 (+3.9%)
Closing price April 29, 2024
Quest Diagnostics is a leading provider of diagnostic testing and services globally. With a focus on delivering comprehensive diagnostic information through routine, advanced clinical, and anatomic pathology testing, it serves a wide range of clients including physicians, hospitals, patients, health plans, and government agencies. Operating under the Quest Diagnostics brand and others like AmeriPath and ExamOne, it has a vast network of laboratories and patient service centers. Additionally, it offers risk assessment services for the life insurance industry and IT solutions for healthcare organizations. Founded in 1967, Quest is headquartered in Secaucus, New Jersey.
These are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research notes: Applied Materials Inc. (NASDAQ: AMAT) Started as Neutral at Susquehanna....
These are the few top pre-market analyst upgrades and positive research notes from Wall Street firms early this Friday morning with about two hours until the market opens: CBS (CBS) Raised to Buy at...
Quest Diagnostics Inc. (NYSE: DGX). Cost pressure strains on the health care sector hurting this stock. New low of $43.65 compared to a 52-week high of $58.63. Consolidated Edison Inc. (NYSE: ED)....
Aventine Renewable Energy (NYSE: AVR) Bad earnings and liquidity issues. Down to $6.79 from 52-week high of $20.85. Life Time Fitness (NYSE: LTM) Bad outlook from 2008. Sells off to $30.40 from...
These aren’t the only analyst calls out there today, but these are the TOP 10 research notes that 24/7 Wall St. is looking at: Aon Corp. (AOC) raised to Buy at Goldman Sachs Aerovironment...
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag.  GlaxoSmithkline (GSK) saw the lagest increase, but its short...
ASML raised to Outperform at Bernstein.CENT cut to Neutral at B of A.COBZ raised to Outperform at KBW.DCP raised to Outperform at CIBC.DGX raised to Buy at UBS.ECL raised to Buy at Jefferies.FNM...
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April.  Below is...